A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast.

Kassandra ThériaultMariem Ben MoussaMarjorie PerronChristine DesbiensBrigitte PoirierÉric PoirierDominique LeblancClaudya MorinJulie LemieuxJean-Charles HogueDominique Boudreau

Published in: The breast journal (2024)

MeBC represents a rare heterogeneous group of malignancies with poor prognosis. Adjuvant chemotherapy was associated with improved OS and DFS. Patients should be carefully selected for neoadjuvant chemotherapy.

Keyphrases

poor prognosis
neoadjuvant chemotherapy
end stage renal disease
long non coding rna
chronic kidney disease
newly diagnosed
locally advanced
ejection fraction
lymph node
sentinel lymph node
prognostic factors
peritoneal dialysis
patient reported outcomes
radiation therapy
early stage
patient reported